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Purpose: To evaluate the demographic and clinical features of childhood pars planitis, 
and to determine the therapeutic and visual outcomes of the disease.
Methods: Medical records of pediatric patients (less than 16 years of age at diagnosis) 
with pars planitis and at least 6 months of follow-up who were referred to Labbafinejad 
Medical Center, Tehran, Iran over a 22 year period were reviewed.
Results: Overall, 117 eyes of 61 patients including 51 (83.6%) male subjects were 
included. Mean age at the time of diagnosis was 7.8±3.2 (range, 3-16) years. Mean 
best corrected visual acuity (BCVA) was 0.88±0.76 logMAR at presentation which 
improved to 0.39±0.51 logMAR at final visit (P<0.001). Endotheliitis was present 
in 23 (19.6%) eyes and was significantly more prevalent in subjects younger than 9 
years (P=0.025). Cataract formation (41.9%) and cystoid macular edema (19.7%) were 
the most prevalent complications. Univariate regression analysis showed that better 
baseline visual acuity (OR=0.38, 95%CI 0.21-0.70, P=0.002), age older than 5 years at 
disease onset (OR=0.36, 95%CI 0.14-0.9, P=0.029), absence of endotheliitis (OR=0.39, 
95%CI 0.15-0.99, P=0.047) and female gender (OR=3.77, 95%CI 1.03-13.93, P=0.046) 
were significantly associated with final BCVA of 20/40 or better.
Conclusion: Childhood pars planitis was much more common among male subjects. 
Endotheliitis may be a sign of inflammation spillover and is more prevalent in younger 
patients. Visual prognosis is favorable in most patients with appropriate treatment.
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INTRODUCTION
Pars planitis is a subset of intermediate uveitis 
characterized by aggregation of inflammatory 
cells and debris over the pars plana (snow 
banks) or in the vitreous cavity (snow balls) 
in the absence of infections or other known 
inflammatory conditions.1 It is a relatively 
common form of childhood and young adult-
onset uveitis.2-4 The prevalence of pars planitis 
varies from 5% to 25% based on reports from 
different uveitis clinics.5-7
Considering the chronic, insidious nature 
of pars planitis and the fact that the anterior 
segment is often quiet in this condition, 
permanent visual loss may occur in children. 
There is lack of information on visual outcomes 
and complications of childhood pars planitis 
in Iran; we therefore reviewed medical records 
of patients with childhood pars planitis at our Childhood Pars Planitis; Nikkhah et al
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center spanning a time period exceeding 20 
years.
METHODS
Hospital records of all patients with childhood 
pars planitis who were referred to Labbafinejad 
Medical Center, a tertiary referral eye care center 
in Tehran-Iran from September 1983 to August 
2005 were reviewed. Patients younger than 
16 years with a classical presentation of pars 
planitis characterized by vitritis and presence 
of snow balls or snow banks, at least in one eye, 
were included. Patients with associated systemic 
or ocular disease, or abnormal laboratory tests 
compatible with a systemic condition known 
to be associated with intermediate uveitis were 
excluded. Only subjects with at least 6 months 
of follow-up were included for the purpose of 
the study.
Data included sex, age at onset of the 
disease, unilateral or bilateral involvement, 
initial ocular symptoms and signs, best-corrected 
visual acuity (BCVA) at presentation and at final 
examination based on Snellen chart or fixation 
pattern in preverbal/non-cooperative children, 
ocular complications and intraocular pressure 
(IOP). Ophthalmologic examination findings in 
detail included band keratopathy, endotheliitis, 
anterior chamber (AC) reaction, anterior vitreous 
reaction, anterior or posterior synechiae and 
cataracts on slit lamp biomicroscopy; and 
snow balls, snow banks, cyclitic membranes, 
peripheral retinal vasculitis, peripheral retinal 
neovascularization, papillitis or optic disc 
atrophy, and cystoid macular edema (CME) 
on fundus examination. CME was detected 
clinically or by fluorescein angiography. We 
also reviewed the results of laboratory tests 
and recorded treatment data including topical 
steroids, subtenon injections of corticosteroids, 
systemic steroids, immunosuppressive agents, 
laser photocoagulation and cryotherapy, as 
well as surgical procedures.
Statistical analysis was performed using 
SPSS software (Version 17.0, SPSS Inc., Chicago, 
USA). Wilcoxon signed rank test was used to 
evaluate the difference between initial and 
final BCVA. Regression analysis (univariate 
and multiple) was used to determine the 
effect of factors such as sex, age and BCVA at 
presentation on final BCVA.
RESULTS
One hundred and seventeen eyes of 61 patients 
including 51 (83.6%) male and 10 (16.4%) female 
subjects were studied. Mean age at diagnosis 
was 7.8±3.2 (range, 3-16) years and mean follow-
up duration was 44.6±37.8 (median, 34; range, 
6-140) months. The condition was bilateral in 56 
patients (91.8%). BCVA was based on fixation 
pattern in 7 eyes and 6 eyes had missing data. 
Mean BCVA was 0.88±0.76 (range, 0.12 to 2.9) 
logMAR at initial examination which was 
significantly improved to 0.39±0.5 (range, 0.12 
to 2.6) logMAR at final follow-up; none of the 
BCVA data was based on fixation patterns at 
final examination. BCVA was 20/40 or better 
in 68 (58.1%) eyes and less than 20/200 in 13 
(11.1%) eyes at final follow-up (Table 1).
The most common symptoms at presentation 
were blurred vision in 46 patients (75%), 
followed by red eye and eye deviation each 
in 6 subjects (10%). Floaters were the initial 
symptom in only 3 cases (5%). The most common 
ocular signs at presentation were snow banks 
in 82 (70.1%), snow balls in 67 (57.3%), vitritis 
in 63 (53.8%), periphlebitis in 44 (37.5%), 
anterior chamber reaction in 31 (26.5%), and 
endotheliitis in 23 (19.7%) eyes. The latter was 
significantly correlated with the age less than 
9 years (P=0.025).
The most frequent complications were 
cataracts in 49 (41.9%), CME in 23 (19.7%), 
band keratopathy in 20 (17.1%), amblyopia 
BCVA
Number (percent)
Initial Final
≥20/40  37 (31.6) 68 (58.1)
20/50-20/200 25 (21.4) 30 (25.6)
<20/200 42 (35.8) 13 (11.1)
Missing data 6 (5.2) 6 (5.2)
CSM 7 (6.0) 0 (0)
M±SD (logMAR) 0.88±0.76 0.39±0.51*
Table 1. Best-corrected visual acuity (BCVA) at initial 
and final examinations
* P<0.001, Wilcoxon Signed-Rank test.
CSM, central, steady, maintained; M, mean; SD, standard 
deviationChildhood Pars Planitis; Nikkhah et al
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in 20 (17.1%), epiretinal membranes (ERMs) 
in 9 (7.7%), ocular hypertension in 7 (6%), 
glaucoma in 7 (6%), vitreous hemorrhage in 
6 (5.1%), retinal detachment in 5 (4.2%), and 
cyclitic membranes and optic atrophy each in 
4 (3.4%) eyes. Posterior subcapsular cataracts 
were the most common form of lens opacities. 
CME and ERM were diagnosed clinically.
The therapeutic regimen included: topical 
corticosteroids in 40 eyes (34.2%), subtenon 
injection of triamcinolone in 86 eyes (73.5%) 
with a total of 253 injections (average of 3 
injections per eye), oral prednisolone in 18 
patients (29.5%), and oral cyclosporine (one 
capsule daily for 2 months) in one subject 
(0.9%). Peripheral retinal photocoagulation 
and cryotherapy were performed in 10 (8.5%) 
and 9 (7.7%) eyes respectively for treatment of 
peripheral retinal neovascularization. Cataract 
extraction was performed in 17 eyes including 
11 eyes with severe lens opacity, of which 6 eyes 
underwent intraocular lens (IOL) implantation. 
Mean BCVA was not significantly different 
between IOL implanted (0.2 logMAR) and non-
IOL implanted eyes (1.05 logMAR) (P=0.147). Six 
other eyes underwent lensectomy without IOL 
implantation as part of pars plana vitrectomy 
to facilitate vitreous base trimming. Pars plana 
vitrectomy was performed on 22 eyes due to 
complications of pars planitis. Indications for 
pars plana vitrectomy included severe vitreous 
organization (13 eyes), vitreous hemorrhage 
(4 eyes), rhegmatogenous retinal detachment 
(RRD, 2 eyes), ERM (2 eyes), tractional retinal 
detachment (1 eye), and previously failed scleral 
buckling (2 eyes). The retina was totally attached 
at final examination in all eyes; however 2 eyes 
required multiple vitreoretinal procedures.
During follow-up, IOP was higher than 
21 mmHg in 14 eyes of 9 patients. IOP 
was controlled in 7 eyes of 5 patients by 
discontinuation of steroids; 4 eyes of 2 patients 
required antiglaucoma medications and 3 eyes 
of 2 patients underwent trabeculectomy.
Univariate logistic regression revealed 
that better BCVA at presentation (OR=0.38, 
95%CI 0.21-0.70, P=0.002), age older than 5 
years at disease onset (OR=0.36, 95%CI 0.14-0.9, 
P=0.029), female gender (OR=3.77, 95%CI 1.03-
13.93, P=0.046) and absence of endotheliitis at 
initial examination (OR=0.39, 95%CI 0.15-0.99, 
P=0.047) were significantly correlated with final 
BCVA of 20/40 or better. However, multiple 
logistic regression disclosed that only BCVA 
at presentation (OR=0.37, 95%CI 0.18-0.74, 
P=0.004) and female gender (OR=10.75, 95%CI 
1.21-95.8, P=0.033) were significantly correlated 
with final BCVA of 20/40 or better (Table 2).
DISCUSSION
Pars planitis is considered a type of intermediate 
uveitis of unknown etiology associated with 
snow ball or snow bank formation. It is not 
associated with any systemic disease and is 
usually bilateral with asymmetric severity. 
Male to female ratio was 5 to 1 in our series, 
however the disease has been reported to be 
more frequent in female subjects in some other 
reports.8,9 The condition was bilateral in 92% of 
our patients. The rate of bilateral disease ranges 
from 84.3% as reported by Garcia et al10
 down 
to 10% as described by Maris et al.11 Mean age 
at diagnosis was 7.8 years in our series which 
is close to corresponding figures of 9.2 years 
reported by Romero et al12, and 10 years by 
Arellanes-Garcia et al10.
Blurred vision was the most common 
Univariate analysis* Simultaneous effect**
OR (95% CI) P OR (95% CI) P
BCVA at presentation 0.38 (0.21 - 0.70) 0.002 0.37  (0.18 - 0.74) 0.004
Age ≤5 years at presentation 0.36 (0.14 - 0.90) 0.029 0.55 (0.15 - 2.03) 0.413
Phlebitis 1.26 (0.48 - 3.27) 0.642 1.26 (0.3 - 5.17) 0.834
AC reaction 0.64  (0.27 - 1.48) 0.293 0.61 (0.2 - 1.93) 0.366
Endotheliitis 0.39 (0.15 - 0.99) 0.047 0.5 (0.15 - 1.7) 0.408
Sex (female) 3.77 (1.03 - 13.93) 0.046 10.75 (1.21 - 95.8) 0.033
Table 2. Effect of different factors on final best corrected visual acuity (BCVA) of 20/40 or better
*Based on logistic regression; **Based on multiple logistic regression
OR, odds ratio; CI, confidence interval; AC, anterior chamberChildhood Pars Planitis; Nikkhah et al
252 JOURNAL OF OPHTHALMIC AND VISION RESEARCH 2011; Vol. 6, No. 4
symptom in our study which is consistent 
with other reports.8,11,12 Although patients 
may complain of decreased vision in one eye, 
both eyes are involved in most cases.13 Ocular 
deviation was the presenting symptom in 11 
patients in our series which emphasizes the 
importance of a complete eye examination in 
any child with strabismus.
The most frequent signs in our study were 
snow banks (70.1%), snow balls (57.3%) and 
vitritis (53.8%). In a series by Raja et al9, vitritis 
(100%) and snow banking (91%) were the most 
common signs. Arellanes-Garcia et al10 reported 
vitritis (99.7%) and snow balls (99.3%) as the 
most frequent signs. Periphlebitis and anterior 
chamber reaction were other common signs on 
initial examination in our series, present in 37.5% 
and 26.5% of eyes respectively. Endotheliitis 
was noted in 23 eyes (19.7%) at presentation. 
Autoimmune endotheliopathy in pars planitis 
was first reported by Khodadoust et al14 in 4 of 
10 patients. Corneal changes in this condition 
are similar to those seen in allograft corneal 
rejection. Although this finding may underscore 
the autoimmune nature of pars planitis, it has 
also been suggested to be due to spillover of 
inflammatory cells from the vitreous cavity.15
Cataract formation and CME have been 
reported as major complications of pars 
planitis.8,10,12 Cataracts (41.9%), CME (19.7%) 
and band keratopathy (17.1%) were the 
predominant complications in our series. 
Posterior subcapsular cataracts were the most 
common form of lens opacity. Romero et al12 
reported cataracts (36.7%), ocular hypertension 
(23.3%) and retinal neovascularization (23.3%) 
as the most frequent complications of pars 
planitis in their series. Cataracts (30.4%), CME 
(26.1%) and ERM (26%) were reported as the 
most prevalent complications by Donaldson 
et al.8 In a Mexican Mestizo population, 
Arellanes-Garcia et al10 reported CME (63.4%) 
and cataracts (47.5%) to be the most common 
complications. Cataracts may develop due to 
corticosteroid therapy or as a sequel to ocular 
inflammation.
In the current study, cataract surgery was 
performed in 11 eyes because of severe lens 
opacity and in 6 eyes as part of pars plana deep 
vitrectomy procedures. Six eyes in the first 
group underwent IOL implantation whereas in 
the second group, all 6 eyes were left aphakic. 
Tessler et al16 randomized 26 patients with 
chronic iridocyclitis or pars planitis to cataract 
surgery with or without IOL implantation and 
found no statistically significant difference in 
visual outcomes between the two groups, a 
finding in line with our results which revealed 
IOL implantation is a safe procedure with good 
results (mean BCVA of 0.2 logMAR).
Fourteen eyes (12%) in our series developed 
ocular hypertension during follow-up, of 
which 7 (6%) responded favorably to steroid 
discontinuation. The remaining 7 eyes (6%) 
developed glaucoma; in 4 eyes, the glaucoma 
was controlled with medications, but 3 other 
eyes underwent trabeculectomy. In the series 
reported by Romero et al12, ocular hypertension 
occurred in 23.3% of eyes but none of them 
developed glaucoma. Arellanes-Garcia10 
reported ocular hypertension and glaucoma 
in 22.7% and 7.5% of eyes in their series, 
respectively. Filtering surgery was required 
in half of the patients with glaucoma.
Vitreous hemorrhage occurred in 5 eyes 
(4.2%) which resolved spontaneously in one 
eye; the other four eyes underwent pars plana 
deep vitrectomy due to nonclearing vitreous 
hemorrhage. Mean BCVA in these eyes was 
0.19 logMAR. Visual outcomes of pars plana 
vitrectomy for vitreous hemorrhage, as reported 
by Potter et al,17 are generally good. Vitreous 
hemorrhage is not a frequent complication of 
pars planitis.11,12,18
In the current study, retinal detachment 
(RD) occurred in 5 eyes of 5 patients (4.2%) 
including tractional RD in one eye and RRD 
in 4 eyes. Romero and coworkers12 reported 3 
patients with RD (10%) in their study. Arellanes-
Garcia et al10 reported RRD in 5 patients (1.7%). 
In the series reported by Malinowski et al19, 
RD occurred in 9 eyes (8.3%). In our series 3 
patients underwent pars plana deep vitrectomy 
and 2 others underwent scleral buckling for 
RD. In two eyes retinal reattachment was 
achieved after multiple vitreoretinal procedures. 
Mean BCVA in RD patients was 0.76 logMAR 
postoperatively. Thirteen eyes of 11 patients Childhood Pars Planitis; Nikkhah et al
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underwent pars plana deep vitrectomy for 
dense vitreous organization and achieved mean 
final BCVA of 0.42 logMAR.
Treatment of pars planitis needs a stepwise 
and individualized approach. In our series, 22 
eyes with mild vitreous involvement, good 
visual acuity (>20/40) and no vision threatening 
complications, received no treatment. In eyes 
with moderate to severe vitritis, periocular 
steroid injections (mostly subtenon) were 
the mainstay of therapy. Oral corticosteroids 
were given in subjects with poor response to 
periocular injections or in cases with severe 
bilateral disease. Topical corticosteroids 
were added if there was associated anterior 
chamber reaction. Systemic immunosuppressive 
agents were required only in one patient to 
control the inflammation. Cryotherapy and 
laser photocoagulation were the last options, 
as suggested by Whitcup.20 Complications 
intractable to medical therapy were managed 
by surgical means.
In our series, mean BCVA at presentation 
was 0.88 logMAR which was improved to 0.39 
logMAR at final examination (P<0.001). BCVA 
of 20/40 or better was present in 37% of eyes 
at presentation and in 68% of eyes at final 
follow-up; 40% of eyes at presentation and 13% 
at final follow-up had BCVA less than 20/200. 
Romero et al12 reported mean BCVA of 0.64 and 
0.84 logMAR at initial and final examinations, 
respectively. Corresponding values were 0.36 
and 0.34 logMAR in the study by Malinowski et 
al19. Both univariate and multivariate regression 
analyses showed that final BCVA of 20/40 or 
better was significantly correlated with better 
BCVA at presentation and with female gender. 
Better baseline BCVA indicates milder disease 
and low grade ocular involvement, on the 
other hand it may reflect earlier diagnosis and 
therefore forecasts better visual outcomes. The 
authors have no explanation for the fact that 
female gender was a good prognostic factor. 
Absence of endotheliitis at presentation and 
age above 5 years at onset were significantly 
associated with final BCVA of 20/40 or better 
only based on univariate analysis. Since pars 
planitis is often quiet and insidious, young 
children and their parents fail to notify any 
problem in the early stages of the disease 
leading to delayed diagnosis and poor visual 
outcomes.
The major limitation of our study is its 
retrospective nature; some data such as BCVA 
at presentation in 6 eyes and final BCVA in 6 
other cases were missing. Moreover, the study 
was performed at a tertiary referral center 
and therefore mild cases were probably not 
included. Therefore these results may not be 
generalizable to all pediatric patients with pars 
planitis. The major conclusion of this study 
is that, childhood pars planitis is a treatable 
disease with good visual prognosis as long 
as early diagnosis, appropriate treatment and 
regular follow-up are provided.
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